Cargando…
The Role of Hypoxia and the Immune System in Tumor Radioresistance
Autores principales: | Span, Paul N., Bussink, Jan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6826392/ https://www.ncbi.nlm.nih.gov/pubmed/31615071 http://dx.doi.org/10.3390/cancers11101555 |
Ejemplares similares
-
Letter to the editor: Hypoxia kinetics and histology in combined radiotherapy and oxidative phosphorylation inhibition effects on antitumor immunity
por: Boreel, Daan F, et al.
Publicado: (2021) -
Changes in DNA Damage Repair Gene Expression and Cell Cycle Gene Expression Do Not Explain Radioresistance in Tamoxifen-Resistant Breast Cancer
por: Post, Annemarie E. M., et al.
Publicado: (2020) -
Critical Role of Aberrant Angiogenesis in the Development of Tumor Hypoxia and Associated Radioresistance
por: Multhoff, Gabriele, et al.
Publicado: (2014) -
Tamoxifen induces radioresistance through NRF2-mediated metabolic reprogramming in breast cancer
por: Naumann, F. V., et al.
Publicado: (2023) -
Genotyping and Characterization of HPV Status, Hypoxia, and Radiosensitivity in 22 Head and Neck Cancer Cell Lines
por: Göttgens, Eva-Leonne, et al.
Publicado: (2021)